Pain News and Research

Latest Pain News and Research

Insilico Medicine highlights AI drug discovery progress at executive summit

Dr. Alex Aliper, Co-founder and President of Insilico Medicine, will attend the AI for Good Global Summit 2026 in Geneva, Switzerland, on July 7.

3 Jul 2026

WHO launches PARTNERS clinical trial for Bundibugyo virus treatments

In a major international effort to evaluate potential treatments for Ebola disease due to Bundibugyo virus (BVD), the PARTNERS clinical trial has opened enrolment today for patients in the Democratic Republic of the Congo.

3 Jul 2026

Can ibuprofen improve drug-resistant tuberculosis treatment?

While ibuprofen reduced inflammatory markers in drug-resistant TB patients, it did not enhance treatment outcomes, indicating the need for further research.

3 Jul 2026

Insilico Medicine partners with Takeda for AI-driven drug discovery

Insilico Medicine, a leader in clinical-stage generative AI for drug discovery, today announced a strategic collaboration agreement with Takeda to use its proprietary end-to-end platform, Pharma.AI, to advance drug candidates across the company's therapeutic areas.

2 Jul 2026

Paracetamol during pregnancy does not raise autism or ADHD risk

A sibling-matched study finds no link between prenatal paracetamol use and autism or ADHD, reassuring its safety when clinically indicated during pregnancy.

2 Jul 2026

Opioid prescribing after pediatric surgery varies widely across hospitals

Whether children receive an opioid prescription after surgery varies substantially by procedure type and hospital, according to a new national analysis published in the Journal of the American College of Surgeons (JACS).

1 Jul 2026

Cannabidiol shows preclinical promise for anxiety, depression and cognition

A new meta-analysis suggests that CBD may improve emotional behavior and cognition in animal models, but researchers caution that its clinical benefits still need to be proven in humans.

1 Jul 2026

Prenatal paracetamol use does not increase child neurodevelopmental risks

Researchers from the University of Hong Kong (HKUMed), along with Aston Pharmacy School's Professor Ian Chi-Kei Wong, have shown that using paracetamol (acetaminophen) during pregnancy does not increase a child's risk of developing autism spectrum disorder (ASD) or attention‑deficit hyperactivity disorder (ADHD).

1 Jul 2026

Novel biomimetic peptide actively rebuilds damaged tooth dentin

Dentin hypersensitivity affects millions of people worldwide, yet existing treatments often provide only temporary relief.

1 Jul 2026

Personalized self-management effectively prevents chronic back pain

Almost everyone will deal with back pain at some point in their lives. Most recover quickly - but for about 20% of people, acute pain becomes a chronic condition that interferes with daily life and keeps them out of the workforce.

1 Jul 2026

New national program targeting harmful and unnecessary medicine use in Australia

...

1 Jul 2026

Melatonin may safely reduce chronic musculoskeletal pain, study finds

A sleep supplement widely used to treat insomnia could help reduce reliance on some of the most common and potentially harmful pain medications, new research from the University of Sydney suggests.

30 Jun 2026

New anti-lipid antibodies could improve diagnosis of Lyme disease

Lyme disease can be easiest to treat in its earliest stages, but current tests often miss infections during that critical window and cannot tell whether bacteria are still present or were cleared years ago.

30 Jun 2026

UCD professor wins ERC grant for pediatric growth disorder research

Professor Niamh Nowlan of University College Dublin (UCD) has been awarded a European Research Council (ERC) Proof of Concept Grant for research with the potential to enable new treatments for a broad range of paediatric growth disorders.

30 Jun 2026

Fiber blend relieves constipation and improves stool consistency

A recent study found that a combination of dietary fibers effectively alleviated chronic constipation, enhancing bowel function and stool quality in adults.

30 Jun 2026

Strong chest and back muscles linked to lower risk of a heart attack

People with strong muscles in their chest and back are less likely to have heart attacks, according to analysis of heart scans using artificial intelligence which was part-funded by the British Heart Foundation and led by the University of Edinburgh.

30 Jun 2026

Genetic research links KDF1 mutation to impaired dental epithelial organization

Dental enamel is the hardest substance in the human body, protecting teeth from wear, temperature changes, and decay. However, enamel cannot regenerate once damaged. Inherited disorders, such as amelogenesis imperfecta, disrupt enamel formation during development, leaving affected individuals with fragile, discolored, and decay-prone teeth.

30 Jun 2026

Telehealth mindfulness program reduces chronic low back pain

Low back pain affects over 600 million people and is the single leading cause of disability worldwide.

29 Jun 2026

Scientists discover 70 existing drugs that block deadly hantavirus infections

Researchers screened over 5,000 compounds and successfully pinpointed 70 existing drugs, including unexpected beta-lactam antibiotics, that effectively suppress Puumala orthohantavirus infection in human cells. This milestone drug-repurposing study provides an immediate, fast-tracked pipeline for developing the first approved treatments against life-threatening hantavirus diseases.

28 Jun 2026

Rare pelvic schwannoma removed with nerve-sparing laparoscopic surgery

Through interdepartmental collaboration, a young woman's quality of life and ability to walk were restored following the laparoscopic removal of a rare, benign tumor of neurological origin in the lesser pelvis, known as a schwannoma (also called a neurinoma).

26 Jun 2026